“…obviously it is a totally separate thing between having an FDA statement versus somewhere like the CDC and ACIP promoting or recommending it, so you know, the FDA statement shows that yes, it can be used, and it is safe and effective, but I think ultimately statements from either the CDC or the American Pediatric Association, those are probably kind of the more influential impacts on actual clinician usage.”
Overview
An interview with a US key opinion leader (KOL) on meningococcal and pneumococcal vaccination coverage rates, vaccination rate trends in main risk groups, key marketed vaccines, pipeline approaches, and addressing unmet needs.